课题基金 / 基金详情

CLINICAL TRIAL: EFFECTS OF COENZYME Q10 IN PARKINSON DISEASE (QE#)

CLINICAL TRIAL: EFFECTS OF COENZYME Q10 IN PARKINSON DISEASE (QE#)
临床试验：辅酶 Q10 对帕金森病 (QE
批准号：
8167263
负责人：
ANDREW FEIGIN
金额：
$1.4万
依托单位：
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-04-01 至 2011-03-31
来源：
https://reporter.nih.gov/project-details/8167263
关键词：
AssesClinical TrialsCoenzyme Q10Computer Retrieval of Information on Scientific Projects DatabaseCreatineDoseFundingGrantImpairmentInstitutionParkinson DiseasePatientsPlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of Health

项目摘要

项目成果

ANDREW FEIGIN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这是一项为期16个月的研究，旨在评估肌酸(两剂)与安慰剂在减缓早期未经治疗的帕金森氏病患者进行性损害方面的效果。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a 16-month study to asses the effects of creatine (two doses) versus placebo on slowing the progressive impairment of Parkinson's disease in early untreated patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
CLINICAL TRIAL: A STUDY OF CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE
海外基金